Critical appraisal of the obesity paradox in cardiovascular disease: How to manage patients with overweight in heart failure?

Heart Failure Reviews

Volumn 19, Issue 5, 2014, Pages 637-644

  Doehner, Wolfram ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Heart failure; Mortality; Obesity; Overweight; Secondary disease prevention

Indexed keywords

INSULIN SENSITIZING AGENT;

AGE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; HEALTH CARE SYSTEM; HEALTH STATUS; HEART FAILURE; HUMAN; HYPERLIPOPROTEINEMIA; HYPERTENSION; METABOLIC SYNDROME X; MORTALITY; OBESITY; PATHOPHYSIOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PRIMARY PREVENTION; RISK ASSESSMENT; SCORING SYSTEM; SECONDARY PREVENTION; SEDENTARY LIFESTYLE; SURVIVAL; TREATMENT OUTCOME; WEIGHT REDUCTION; COMPLICATION; OVERWEIGHT; RISK FACTOR;

BODY MASS INDEX; HEART FAILURE; HUMANS; OVERWEIGHT; RISK FACTORS; WEIGHT LOSS;

EID: 84906938046     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-014-9425-z     Document Type: Article

References (81)

1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M et al (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:222-260
2. Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis D, Anker SD (2000) Obesity and survival in chronic heart failure. Circulation 102(Suppl I):I4202
3. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH (2001) The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38:789-795 (Pubitemid 32835754)
4. Guglin M, Baxi K, Schabath M (2013) Anatomy of the obesity paradox in heart failure. Heart Fail Rev. doi:10.1007/s10741-013-9406-7
5. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M et al (2012) European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 33:1635-1701
6. Lissin LW, Gauri AJ, Froelicher VF, Ghayoumi A, Myers J, Giacommini J (2002) The prognostic value of body mass index and standard exercise testing in male veterans with congestive heart failure. J Card Fail 8:206-215
7. Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis DP, Coats AJ, Clark AL, Anker SD (2003) Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 9:29-35 (Pubitemid 36356699)
8. Lavie CJ, Osman AF, Milani RV, Mehra MR (2003) Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 91:891-894 (Pubitemid 36363743)
9. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC (2004) Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43:1439-1444 (Pubitemid 38496352)
10. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM (2005) The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165:55-61 (Pubitemid 40096082)
11. Gustafsson F, Kragelund CB, Torp-Pedersen C, Seibaek M, Burchardt H, Akkan D, Thune JJ, Kober L (2005) Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J 26:58-64 (Pubitemid 40221124)
12. Bozkurt B, Deswal A (2005) Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J 150:1233-1239 (Pubitemid 41773528)
13. Butler J, Howser R, Portner PM, Pierson RN 3rd (2005) Body mass index and outcomes after left ventricular assist device placement. Ann Thorac Surg 79:66-73 (Pubitemid 40037441)
14. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M (2007) An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 153:74-81 (Pubitemid 44880872)
15. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD (2007) Body mass index and prognosis in patients with chronic heart failure: insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation 116:627-636 (Pubitemid 47356347)
16. Cicoira M, Maggioni AP, Latini R, Barlera S, Carretta E, Janosi A, Soler Soler J, Anand I, Cohn JN (2007) Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan heart failure trial. Eur J Heart Fail 9:397-402 (Pubitemid 46454390)
17. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA (2008) Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156:13-22 (Pubitemid 351862293)
18. Chase P, Arena R, Myers J, Abella J, Peberdy MA, Guazzi M, Bensimhon D (2008) Relation of the prognostic value of ventilatory efficiency to body mass index in patients with heart failure. Am J Cardiol 101:348-352 (Pubitemid 351162966)
19. Abdulla J, Køber L, Abildstrøm SZ, Christensen E, James WP, Torp-Pedersen C (2008) Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries. Eur Heart J 29:594-601
20. Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, Ostergren J, Pfeffer MA, Solomon SD, Anker SD, Swedberg KB (2008) Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J 29:2641-2650
21. Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, Moore B, Kitzman D, Peberdy MA, Bensimhon D, Chase P, Forman D, West E, Guazzi M (2009) Influence of etiology of heart failure on the obesity paradox. Am J Cardiol 104:1116-1121
22. Kapoor JR, Heidenreich PA (2010) Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship. Am Heart J 159:75-80
23. Choy B, Hansen E, Moss AJ, McNitt S, Zareba W, Goldenberg I (2010) Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction. Am J Cardiol 105:581-586
24. Doesch C, Suselbeck T, Leweling H, Fluechter S, Haghi D, Schoenberg SO, Borggrefe M, Papavassiliu T (2010) Bioimpedance analysis parameters and epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure. Obesity (Silver Spring) 18:2326-2332
25. Clark AL, Fonarow GC, Horwich TB (2011) Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J Card Fail 17:374-380
26. Futter JE, Cleland JG, Clark AL (2011) Body mass indices and outcome in patients with chronic heart failure. Eur J Heart Fail 13:207-213
27. Gastelurrutia P, Pascual-Figal D, Vazquez R, Cygankiewicz I, Shamagian LG, Puig T, Ferrero A, Cinca J, de Luna AB, Bayes-Genis A (2011) Obesity paradox and risk of sudden death in heart failure results from the MUerte Subita en Insuficiencia cardiaca (MUSIC) study. Am Heart J 161:158-164
28. Casas-Vara A, Santolaria F, Fernandez-Bereciartua A, Gonzalez-Reimers E, Garcia-Ochoa A, Martinez-Riera A (2012) The obesity paradox in elderly patients with heart failure: analysis of nutritional status. Nutrition 28:616-622
29. Schwartzenberg S, Benderly M, Malnick S, George J, Goland S (2012) The, "obesity paradox": does it persist among Israeli patients with decompensated heart failure? A subanalysis of the heart failure survey in Israel (HFSIS). J Card Fail 18:62-67
30. Clark AL, Chyu J, Horwich TB (2012) The obesity paradox in men versus women with systolic heart failure. Am J Cardiol 110:77-82
31. Zamora E, Lupon J, de Antonio M, Urrutia A, Coll R, Diez C, Altimir S, Bayes-Genis A (2013) The obesity paradox in heart failure: is etiology a key factor? Int J Cardiol 166:601-605
32. Nagarajan V, Cauthen CA, Starling RC, Tang WH (2013) Prognosis of morbid obesity patients with advanced heart failure. Congest Heart Fail 19:160-164
33. Zuchinali P, Souza GC, Alves FD, d'Almeida KS, Goldraich LA, Clausell NO, Rohde LE (2013) Triceps skinfold as a prognostic predictor in outpatient heart failure. Arq Bras Cardiol 101:434-441
34. Padwal R, McAlister FA, McMurray JJ, Cowie MR, Rich M, Pocock S, Swedberg K, Maggioni A, Gamble G, Ariti C, Earle N, Whalley G, Poppe KK, Doughty RN, Bayes-Genis A (2013) The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond). doi:10.1038/ijo.2013.203
35. Puig T, Ferrero-Gregori A, Roig E, Vazquez R, Gonzalez-Juanatey JR, Pascual-Figal D, Delgado J, Alonso-Pulpon L, Borras X, Mendez A, Cinca J (2014) Prognostic value of body mass index and waist circumference in patients with chronic heart failure (Spanish REDINSCOR Registry). Rev Esp Cardiol 67:101-106
36. Shah R, Gayat E, Januzzi JL, Sato N, Cohen-Solal A, Disomma S, Fairman E, Harjola VP, Ishihara S, Lassus J, Maggioni A, Metra M, Mueller C, Mueller T, Parenica J, Pascual-Figal D, Peacock F, Spinar J, van Kimmenade R, Mebazaa A, For the GREAT Network (2013) Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol. doi:10.1016/j.jacc.2013.09.072
37. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Papacosta O, Sattar N (2014) The obesity paradox in men with coronary heart disease and heart failure: the role of muscle mass and leptin. Int J Cardiol 171:49-55
38. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ (1997) Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349:1050-1053 (Pubitemid 27158249)
39. Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361:1077-1083 (Pubitemid 36369559)
40. Coutinho T, Goel K, Corrêa de Sá D, Carter RE, Hodge DO, Kragelund C, Kanaya AM, Zeller M, Park JS, Kober L, Torp-Pedersen C, Cottin Y, Lorgis L, Lee SH, Kim YJ, Thomas R, Roger VL, Somers VK, Lopez-Jimenez F (2013) Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol 61:553-560
41. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486-2497
42. Wildman RP, Muntner P, Reynolds K et al (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 168:1617-1624
43. Karelis AD, Rabasa-Lhoret R (2008) Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab 34:183-184
44. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Häring HU (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168:1609-1616
45. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D'Agostino RB (2006) Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91:2906-2912 (Pubitemid 44271734)
46. Doehner W, Pfeiffer AF (2014) Is all obesity the same? The skills to distinguish. Diabetes Care 37:e1. doi:10.2337/dc132748
47. Look AHEAD Research Group (2013) Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369:145-154
48. Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J, PROactive investigators (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone clinical trial in macrovascular events): a randomised controlled trial. Lancet 366:1279-1289 (Pubitemid 41416583)
49. Doehner W, Erdmann E, Cairns R, Clark AL, Dormandy JA, Ferrannini E, Anker SD (2012) Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol 162:20-26
50. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M (2006) The Seattle heart failure model: prediction of survival in heart failure. Circulation 113:1424-1433 (Pubitemid 43739439)
51. Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, Køber L, Squire IB, Swedberg K, Dobson J, Poppe KK, Whalley GA, Doughty RN (2013) Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Meta-analysis global group in chronic heart failure. Eur Heart J 34:1404-1413
52. Schulze PC, Gielen S, Adams V, Linke A, Möbius-Winkler S, Erbs S, Kratzsch J, Hambrecht R, Schuler G (2003) Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulin like growth factor-I in chronic heart failure. Basic Res Cardiol 98:267-274 (Pubitemid 36874026)
53. Doehner W, Rauchhaus M, Ponikowski P, Godsland IF, von Haehling S, Okonko DO, Leyva F, Proudler AJ, Coats AJ, Anker SD (2005) Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 46:1019-1026 (Pubitemid 41316509)
54. Anker SD, Volterrani M, Pflaum CD, Strasburger CJ, Osterziel KJ, Doehner W, Ranke MB, Poole-Wilson PA, Giustina A, Dietz R, Coats AJ (2001) Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol 38:443-452 (Pubitemid 32725023)
55. Sengenes C, Bouloumie A, Hauner H, Berlan M, Busse R, Lafontan M, Galitzky J (2003) Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J Biol Chem 278:48617-48626 (Pubitemid 41079500)
56. Szabó T, Postrach E, Mähler A, Kung T, Turhan G, von Haehling S, Anker SD, Boschmann M, Doehner W (2013) Increased catabolic activity in adipose tissue of patients with chronic heart failure. Eur J Heart Fail 15:1131-1137
57. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, Poole-Wilson PA, Coats AJ (1997) Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96:526-534 (Pubitemid 27329429)
58. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147-e239
59. ESC Committee for Practice Guidelines (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803-869
60. Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, Pepine CJ (2007) Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 120:863-870 (Pubitemid 47451305)
61. Kadakia MB, Fox CS, Scirica BM, Murphy SA, Bonaca MP, Morrow DA (2011) Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial. Heart 97:1782-1787
62. Diercks DB, Roe MT, Mulgund J, Pollack CV Jr, Kirk JD, Gibler WB, Ohman EM, Smith SC Jr, Boden WE, Peterson ED (2006) The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of unstable angina patients suppress ADverse outcomes with early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. Am Heart J 152:140-148 (Pubitemid 44040849)
63. Buettner HJ, Mueller C, Gick M, Ferenc M, Allgeier J, Comberg T, Werner KD, Schindler C, Neumann FJ (2007) The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J 28:1694-1701 (Pubitemid 47227103)
64. Kennedy LM, Dickstein K, Anker SD, Kristianson K, Willenheimer R, OPTIMAAL Study Group (2005) The prognostic importance of body mass index after complicated myocardial infarction. J Am Coll Cardiol 45:156-158 (Pubitemid 40052042)
65. Kennedy LM, Dickstein K, Anker SD, James M, Cook TJ, Kristianson K, Willenheimer R (2006) Weight-change as a prognostic marker in 12 550 patients following acute myocardial infarction or with stable coronary artery disease. Eur Heart J 27:2755-2762 (Pubitemid 44872752)
66. Doehner W, Schenkel J, Anker SD, Springer J, Audebert HJ (2013) Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial. Eur Heart J 34:268-277
67. Sierra-Johnson J, Wright SR, Lopez-Jimenez F, Allison TG (2005) Relation of body mass index to fatal and nonfatal cardiovascular events after cardiac rehabilitation. Am J Cardiol 96:211-214 (Pubitemid 40978576)
68. Badheka AO, Rathod A, Kizilbash MA, Garg N, Mohamad T, Afonso L, Jacob S (2010) Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med 123:646-651
69. Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, Satler LF, Lindsay J Jr (2002) The impact of obesity on the shortterm and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 39:578-584 (Pubitemid 34158151)
70. Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T (2013) Obesity paradox in Japanese patients after percutaneous coronary intervention: an observation cohort study. J Cardiol 62:18-24
71. Nikolsky E, Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Negoita M, Lansky AJ, Mehran R (2006) Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction. Am Heart J 151:168-175 (Pubitemid 41815349)
72. Ndrepepa G, Keta D, Byrne RA, Schulz S, Mehilli J, Seyfarth M, Schömig A, Kastrati A (2010) Impact of body mass index on clinical outcome in patients with acute coronary syndromes treated with percutaneous coronary intervention. Heart Vessel 25:27-34
73. van der Boon RM, Chieffo A, Dumonteil N, Tchetche D, Van Mieghem NM, Buchanan GL, Vahdat O, Marcheix B, Serruys PW, Fajadet J, Colombo A, Carrié D, van Domburg RT, PP de Jaegere PP, RAGMATIC-Plus Researchers (2013) Effect of body mass index on short- and long-term outcomes after transcatheter aortic valve implantation. Am J Cardiol 111:231-236
74. Jackson RS, Black JH 3rd, Lum YW, Schneider EB, Freischlag JA, Perler BA, Abularrage CJ (2012) Class I obesity is paradoxically associated with decreased risk of postoperative stroke after carotid endarterectomy. J Vasc Surg 5:1306-1312
75. Potapov EV, Loebe M, Anker S, Stein J, Bondy S, Nasseri BA, Sodian R, Hausmann H, Hetzer R (2003) Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery. Eur Heart J 24:1933-1941 (Pubitemid 37322703)
76. Le-Bert G, Santana O, Pineda AM, Zamora C, Lamas GA, Lamelas J (2011) The obesity paradox in elderly obese patients undergoing coronary artery bypass surgery. Interact CardioVasc Thorac Surg 13:124-127
77. Stamou SC, Nussbaum M, Stiegel RM, Reames MK, Skipper ER, Robicsek F, Lobdell KW (2011) Effect of body mass index on outcomes after cardiac surgery: is there an obesity paradox? Ann Thorac Surg 91:42-47
78. Sung SH, Wu TC, Huang CH, Lin SJ, Chen JW (2011) Prognostic impact of body mass index in patients undergoing coronary artery bypass surgery. Heart 97:648-654
79. Florath I, Albert AA, Rosendahl UP, Hassanein WM, Bauer S, Ennker IC, Ennker JC (2006) Body mass index: a risk factor for 30-day or six-month mortality in patients undergoing aortic valve replacement? J Heart Valve Dis 15:336-344
80. van Kuijk JP, Flu WJ, Galal W, Chonchol M, Goei D, Verhagen HJ, Bax JJ, Poldermans D (2011) The influence of polyvascular disease on the obesity paradox in vascular surgery patients. J Vasc Surg 53:399-406
81. Davenport DL, Xenos ES, Hosokawa P, Radford J, Henderson WG, Endean ED (2009) The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality. J Vasc Surg 49:140-147